Researchers worldwide are still working around the clock to find a vaccine

against SARS-CoV-2, the virus causing the COVID-19 pandemic.

Potential/Experimental COVID-19 Vaccines

As of November 24, 2020, large-scale (Phase 3) clinical trials are in
progress or being planned for COVID-19 vaccines:
 AstraZeneca’s COVID-19 vaccine
 Janssen’s COVID-19 vaccine
 Moderna’s COVID-19 vaccine
 Novavax’s COVID-19 vaccine
 Pfizer’s COVID-19 vaccine
 China’s Sinovac COVID-19 vaccine

COVID-19 Vaccine in the Philippines

Last November 27, the Philippine government signed a supply
agreement for 2.6 million doses of AstraZeneca’s coronavirus disease
(COVID-19) vaccine.
The purchase deal for the experimental vaccine developed by the
British pharmaceutical giant with the University of Oxford will support the
Philippine government’s plans to immunize against COVID-19.
The first supply of the experimental vaccine will help more than 1
million Filipinos since each person needs two doses.
The vaccine supply will be fully paid for by private firms, but half of
it will be donated to the government to help in the COVID-19 response. It is
expected to arrive by the second quarter of 2021 (April or May).
The government is still seeking 20 million to 50 million vaccine
doses from China's Sinovac and US firm Pfizer among others in its fight
against COVID-19.